Quanlin An

Carbohydrate-based drugs launched during 2000−2021

Jing Wang, P. Fang, Xin Cao, 2022, Acta pharmaceutica Sinica. B.

Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway

B. Niu, W. Qin, Junwei Chen, 2021, Journal of experimental & clinical cancer research : CR.

Synthetic Retinoid Kills Drug‐Resistant Cancer Stem Cells via Inducing RARγ‐Translocation‐Mediated Tension Reduction and Chromatin Decondensation

Ning Wang, B. Niu, Junwei Chen, 2022, Advanced science.

Role of miR-221/222 in Tumor Development and the Underlying Mechanism

B. Niu, Xiaoling Lu, Ning Zhang, 2019, Journal of oncology.

Towards the overcoming of anticancer drug resistance mediated by p53 mutations.

Y. Assaraf, Xiangdong Wang, Jiayun Hou, 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors

Y. Assaraf, Biwei Yang, J. Xia, 2021, Innovation.

Inhibition of cancer stem cell like cells by a synthetic retinoid

Ning Wang, Junwei Chen, Q. Jia, 2018, Nature Communications.

Renal tubule-targeted dexrazoxane suppresses ferroptosis in acute kidney injury by inhibiting ACMSD

Jianhua Mao, Weiqiang Lin, S. Feng, 2023, Nano Research.

Inhibition of cancer stem cell like cells by a synthetic retinoid

Ning Wang, Q. Jia, Biao Yu, 2018, Nature Communications.

AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity.

Xin Cao, Quanlin An, Ni Yan, 2023, Journal of medicinal chemistry.

Retinoids offer new and promising cancer therapeutic avenues

Y. Assaraf, C. Xin, Quanlin An, 2019, Journal of Molecular and Clinical Medicine.